There is so much that scientists have yet to learn about the universe, and understanding the matter that makes up the universe is a large task for scientists to undertake. Researchers at Stony Brook University will soon have new opportunities to increase their research thanks to a newly established research center.Read More
Science Market Update
The National Institute of Mental Health recently awarded a $2.3M Biobehavioral Research Award for Innovative New Scientists (BRAINS) grant to Dr. Matthew D. Lerner, an assistant professor in the Department of Psychology at Stony Brook University. The grant will provide funding for Dr. Lerner's project, “Optimizing Prediction of Social Deficits in Autism Spectrum Disorders,” a study which aims to help youth with autism overcome social challenges.
For over 50 years, Stony Brook University in New York has been a venue for thousands of groundbreaking discoveries made by prominent medical researchers and clinicians.Read More
Getting a fungal infection is a part of life, that everyone experiences at one time or another. These types of infections range in seriousness, from athlete's foot to ringworm to histoplasmosis. Although commonly fatal, more than 1.3 million people contract fatal fungal infections each year. Currently, there are three known antifungal drugs available to fight these infections, though they are not always the most effective. (Image courtesy of L. Shyamal via Wikimedia Commons)Read More
Insulin is a vital hormone that plays a major role in the metabolism: without insulin, humans would not be able to break down carbohydrates or digest food for energy. Insulin lowers blood glucose levels, stores excess glucose as glycogen and reduces glucose production in the liver. Many people, however, have trouble using insulin effectively. Forms of insulin resistance can lead to pre-diabetes or type 2 diabetes, as well as other serious health problems.
Stony Brook University recently named an endowed professor for cancer research at an Investiture Ceremony this spring. Dr. Yusuf A. Hannun will have a sizeable amount of science research funding available for conducting cancer research as the Joel Strum Kenny Professor in Cancer Research. Dr. Hannun is a research lab scientist well-known around the globe for his cancer research and already serves as Director of the Stony Brook University Cancer Center.
Stony Brook University recently received $60 million in new funding to build a state-of-the-art Innovation and Discovery Center on its Research and Development Park campus. The center will include 200,000 square feet of new lab space at Stony Brook University as well as office space for startup businesses. The new funding comes from Governor Andrew M. Cuomo’s START-UP NY initiative, which aims to give businesses tax breaks to start up, relocate, or add new locations in New York by working with New York public and private universities.
Researchers at Stony Brook University recently received $1.2 million in life science funding from the NIH for a Sphingolipids in Cancer Biology and Therapy project led by Yusuf Awni Hannun. According to Stony Brook University, Dr. Hanuun is a renowned molecular biologist and physician-researcher interested in the molecular mechanisms of cancer. In 2012, he was appointed director of the Stony Brook Cancer Center, and he also serves as the Joel Kenny Professor of Medicine and Vice Dean for Cancer Medicine. The NIH RePORTER gives some background information on the project receiving NIH life science research funding:
Reading our Science Market Update blog is a great way to stay informed of industry trends and research, funding and life science building news, but did you know that there is also a great deal of funding and life science market news available on our company news blog? We have put together a list, including links to the articles, of some recent news posted on our Life Science Company and Industry News Briefs blog available to life science sales and marketing professionals interested in staying informed of life science marketing and industry news.
Tags: 2014, University of California Los Angeles, Harvard University, Rockefeller University, University of Arizona, University of Pittsburgh, Pennsylvania, Northeast, University of Pennsylvania, UPenn, New York, UPITT, Southwest, California, Los Angeles, Alabama, University of Alabama, Southern, Massachusetts, Life Science Company and Industry News Briefs, Arizona, Boston, LAVS, Philadelphia, UAZ, RockU, BioResearch Product Faire Event, UAlab, Harvard, Birmingham, Front Line, Tucson, Pittsburgh, Stony Brook, industry news, funding news, Science Market Update, Science Researcher Update, NIH grants, life science events, SunySB
Researchers at Stony Brook University in collaboration with colleagues at Johns Hopkins School of Medicine used DNA sequencing methods to make a new discovery: the direct causation of exposure to aristolochic acid (AA), which is found in a plant that’s been used in herbal remedies for thousands of years, in the development of urothelial cancer.